Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective

@article{TomCarneiro2013ResveratrolIP,
  title={Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective},
  author={Jo{\~a}o Tom{\'e}-Carneiro and Manuel Gonz{\'a}lvez and Mar Larrosa and Mar{\'i}a Josefa Y{\'a}{\~n}ez-Gasc{\'o}n and Francisco J. Garc{\'i}a-Almagro and Jos{\'e} A. Ruiz-Ros and Francisco A. Tom{\'a}s-Barber{\'a}n and Maria Teresa Garcia-Conesa and Juan Carlos Esp{\'i}n},
  journal={Annals of the New York Academy of Sciences},
  year={2013},
  volume={1290}
}
Primary prevention of cardiovascular disease (CVD) aims to avoid a first event in subjects that are at risk but have not yet been diagnosed with heart disease. Secondary prevention of CVD aims to avoid new events in patients with established heart disease. Both approaches involve clinical intervention and implementation of healthy lifestyles. The grape and wine polyphenol resveratrol (3,5,4′‐trihydroxy‐trans‐stilbene) has shown cardioprotective benefits in humans. Most of these approaches deal… 
Potential of resveratrol in the treatment of heart failure.
TLDR
The concept of food has expanded beyond its traditional role of survival and hunger satisfaction, to include a role in the prevention and treatment of disease, and the current status of resveratrol research on cardioprotection is discussed.
The role of phytochemicals as micronutrients in health and disease
TLDR
Evidence for the role of phytochemicals in health and disease is growing, but associations between phytochemistryicals and disease need to be more firmly understood and established from more robust clinical data using preparations that have been phytochemicalically characterized.
OTC Antioxidant Products for the Treatment of Cardiovascular and other Disorders: Popular Myth or Fact?
TLDR
The beneficial effects of these antioxidants are focused mainly against pathogenesis of atherosclerosis, as the primary contributor to coronary artery disease and resulting cardiovascular complications.
Resveratrol levels and all-cause mortality in older community-dwelling adults.
TLDR
In older community-dwelling adults, total urinary resveratrol metabolite concentration was not associated with inflammatory markers, cardiovascular disease, or cancer or predictive of all-cause mortality, and resver atrol levels achieved with a Western diet did not have a substantial influence on health status and mortality risk.
RESVERATROL: RECOMMENDING ITS WIDE INCREASE – A PREMATURE DECISION OR NOT? A REVIEW
Resveratrol, an antioxidant found in red wine and certain foods, has been touted as a natural way to slow aging and fight cancer, obesity, heart disease, and diabetes. It also could be accounted as
Current evidence on the effect of dietary polyphenols intake on chronic diseases.
  • C. Costa, A. Tsatsakis, +8 authors C. Fenga
  • Medicine
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  • 2017
TLDR
This comprehensive review of the current evidence defining the position of polyphenols in the prevention/treatment of human chronic diseases, including prostate cancer and other types of cancer, cardiovascular diseases, diabetes mellitus and neurodegenerative diseases such as Alzheimer's and Parkinson's disease focuses on their ability to modulate multiple signalling transduction pathways involved in the pathophysiology of these diseases.
Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome
TLDR
D diets based on negative-energy-balance, the Mediterranean dietary pattern, n-3 fatty acids, total antioxidant capacity and meal frequency, and dietary fiber content are some of the most relevant aspects related to insulin resistance and impaired glucose tolerance, which are important co-morbidities of MetS.
Metabolic effects of resveratrol: addressing the controversies
TLDR
There are a number of controversies surrounding resveratrol that have not been resolved and this work will review these controversies with particular emphasis on its mechanism of metabolic action and how lessons from resver atrol may help develop therapies that harness the effects of resverAtrol but without the undesirable properties.
Resveratrol: a supplementation for men or for
TLDR
The use of resveratrol as a supplement is not yet justified by the existing evidence, as many questions remain still unsolved, such as the dose or the duration of treatment to maximize its effects, the bioavailability and the role of food matrix to improve its bioactivity.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 93 REFERENCES
One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.
TLDR
1-year consumption of a resveratrol-rich grape supplement improved the inflammatory and fibrinolytic status in patients who were on statins for primary prevention of CVD and at high CVD risk (i.e., with diabetes or hypercholesterolemia plus ≥1 other CV risk factor).
Resveratrol: a cardioprotective substance
TLDR
Results of in vitro and animal studies showing that resveratrol exerts multifaceted cardioprotective activities are summarized, as well as evidence demonstrating the presence of proteins specifically targeted by resver atrol, as exemplified by N‐ribosyldihydronicotinamide:quinone oxidoreductase, NQO2.
Resveratrol in cardiovascular disease: what is known from current research?
TLDR
The cardiovascular protective capacities of resveratrol are associated with multiple molecular targets and may lead to the development of novel therapeutic strategies for atherosclerosis, ischemia/reperfusion, metabolic syndrome, and heart failure.
Does surveillance impact on cardiovascular prevention?
TLDR
In most industrialized countries CHD mortality has decreased since 1960, but in others it has increased, and time trends have been described for total cholesterol, smoking habit, blood pressure, and body mass index, however, the comparability of mortality and risk factors data was poor.
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
TLDR
This review will focus on the currently available evidence regarding resveratrol’s effects on humans obtained from randomized clinical trials and provide a critical outlook for further research on this molecule that is evolving from a minor dietary compound to a possible multi-target therapeutic drug.
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
TLDR
This GE-RES reduced atherogenic markers and might exert additional cardioprotection beyond the gold-standard medication in patients from PCP.
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study
TLDR
Raised residual CVD risk is relatively frequent among patients despite control of their primary risk factors and should be addressed, and there is substantial between-country variation, which indicates additional room for improvement.
Cardioprotection by resveratrol : A human clinical trial in patients with stable coronary artery disease
Several beneficial effects of resveratrol (RES), a natural antioxidant present in red wine have already been described. The aim of our study was to investigate if RES had a clinically measurable
High-Dose Resveratrol Supplementation in Obese Men
TLDR
The lack of effect disagrees with persuasive data obtained from rodent models and raises doubt about the justification of resveratrol as a human nutritional supplement in metabolic disorders.
...
1
2
3
4
5
...